Biocon likely to seek full marketing authorisation for Covid-19 drug
Bangalore-headquartered Biocon may consider applying for full marketing authorisation for itolizumab, a novel antibody product used to treat
Read moreBangalore-headquartered Biocon may consider applying for full marketing authorisation for itolizumab, a novel antibody product used to treat
Read moreIt has been more than six months since the first Covid-19 infection was reported. Now, even as
Read more